bearish
WuXi AppTec (2359.HK/603259.CH) 2023 Results - Time to Prepare for the Worst
Xinyao has highlighted this Insight as a Top Pick
608 Views20 Mar 2024 08:55
WuXi AppTec’s 2023 results were disappointing. 2024 performance guidance is meaningless due to the increasingly intense geopolitical conflicts. It's time to prepare for the worst impact on valuation.
Boomeranged on Tue, 2 Apr 2024 09:20
Here are new updates: Mike Gallagher & Raja Krishnamoorthi sent a letter to the Pentagon to push for related China companies/subsidiaries to be added to a Pentagon list of firms that allegedly work with the Chinese military. Meanwhile, officials from multiple US agencies told the senators they were concerned about WuXi transferred US client’s IP to Chinese authorities.
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
Top 5%
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
Price Chart(Sign Up to Access)
- WuXi XDC Cayman (2268.HK) - Don't Rush to Bottom Fish This Stock01 Apr 2024
- China Resources Sanjiu (000999.CH) - 2023 Results Below Expectations; Short-Term Headwinds Remain25 Mar 2024
- China Healthcare Weekly (Mar.22)-TCM Injection Revive, China CXO Lag Behind in GLP-1, United Imaging24 Mar 2024
- Important New Policy for China’s Innovative Drugs – The Game Rule Is About to Change Radically18 Mar 2024
- Latest Impact of the US Biosecure Act on WuXi AppTec/WuXi Bio/WuXi XDC - China CXO Really Game Over?05 Feb 2024
- WuXi AppTec (2359.HK/603259.CH) - Behind the Plunge Is a War29 Jan 2024
x